Background Proprotein convertase subtilisin/kexin type 9 (PCSK 9) is involved in cholesterol
homeostasis, inflammation, and oxidative stress. This study investigated the association of …

Objective—Proprotein convertase subtilisin/kexin type 9 (PCSK9) plays an important role in
the modulation of low-density lipoprotein metabolism. This study was conducted to evaluate …

Background Proprotein convertase subtilisin/kexin type-9 (PCSK9) is an enzyme promoting
the degradation of low-density lipoprotein receptors (LDL-R) in hepatocytes. Inhibition of …

Objective Recent studies have suggested that proprotein convertase subtilisin/kexin type 9
(PCSK9) is associated with atherosclerosis and plays a potential role in inflammation …

Background Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a key regulator of
serum low-density lipoprotein (LDL) cholesterol levels. Recently, PCSK9 has additionally …

Aims Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a secreted protein that
enhances degradation of the LDL receptor. While agents that inhibit PCSK9 markedly …

Purpose Circulating endothelial progenitor cells (cEPCs) are vital to vascular repair by re-
endothelialization. We aimed to explore the effect of proprotein convertase subtilisin kexin …

Protease proprotein convertase subtilisin/kexin type 9 (PCSK9) is a regulator of LDL
cholesterol clearance and has been associated with cardiovascular risk. PCSK9 inhibitors …

Background—The secreted protein proprotein convertase subtilisin/kexin type 9 (PCSK9) is
a promising new target for lowering plasma low-density lipoprotein cholesterol and …

Abstract Background Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9) levels have
been suggested as novel atherosclerotic biomarker. PCSK9 plays important roles in the …